Can an acute dosage of Bacopa Monniera (brahmi) improve cognition, cardiovascular function and stress in an elderly populatio
- Conditions
- Cognitive function in healthy elderly individualsMental Health - Studies of normal psychology, cognitive function and behaviourCardiovascular function in healthy elderly individualsStressAlternative and Complementary Medicine - Herbal remediesCardiovascular - Normal development and function of the cardiovascular system
- Registration Number
- ACTRN12611001230943
- Lead Sponsor
- Swinburne University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
1.) Healthy non-smoking males and females aged 65 and over
2.) Free from and no history of psychiatric disorders
3.) No neurological diseases or history of neurological diseases
4.) Not suffering from endocrine, gastrointestinal or bleeding disorders
5.) No history of chronic illness/infection
6.) Not currently pregnant or lactating
7.) Must not be taking any medications or herbal extracts
8.) Must have corrected to normal vision
1.) smoker
2.) history of psychiatric disorders
3.) neurological diseases or history of neurological diseases
4.) endocrine, gastrointestinal or bleeding disorders
5.) history of chronic illness/infection
6.) pregnant or lactating
7.) taking any medications or herbal extracts
8.) vision impairment not corrected
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive Function using Cognitive Drug Research (CDR) battery, Swinburne University Computerised Cognitive aging Battery (SUCCAB) battery[Baseline and 2hours post dose];Cardiovascular function using transcranial doppler ultrasound and arterial stiffness measure (using sphygmocor system)[Baseline and 2hours post dose]
- Secondary Outcome Measures
Name Time Method Stress/mood using multitasking battery to induce stress and mood questionnaires before and after stress task[Baseline and 2hours post dose]